Ruthigen Inc. (RTGN) Stock News

USA - NASDAQ:RTGN -

5.06

+1.01 (+24.94%)

Last: 6/15/2015, 8:10:00 PM

4.93

-0.13 (-2.57%)

After Hours: 6/15/2015, 8:10:00 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

RTGN Latest News, Press Relases and Analysis

All

Press Releases

12 days ago - By: RetinalGeniX Technologies, Inc.

RetinalGenix Technologies Contracts with Seer Bio to Explore Early Detection of Neurodegenerative, Systemic, and Retinal Diseases

12 days ago - By: RetinalGeniX Technologies, Inc. - Mentions: SEER

RetinalGenix Technologies Contracts with Seer Bio to Explore Early Detection of Neurodegenerative, Systemic, and Retinal Diseases

a month ago - By: RetinalGeniX Technologies, Inc.

RetinalGenix Technologies and RGEN Clinical Genotyping Laboratory Announce Strategic Collaboration to Advance Early Detection of Neurodegenerative, Systemic, and Retinal Diseases

a month ago - By: RetinalGeniX Technologies, Inc.

RetinalGenix Technologies and RGEN Clinical Genotyping Laboratory Announce Strategic Collaboration to Advance Early Detection of Neurodegenerative, Systemic, and Retinal Diseases

a month ago - By: RetinalGeniX Technologies, Inc.

RetinalGenix Technologies Advances Home and Remote Monitoring Patent Portfolio, Positioning for the Future of Ocular and Systemic Disease Care

a month ago - By: RetinalGeniX Technologies, Inc.

RetinalGenix Technologies Advances Home and Remote Monitoring Patent Portfolio, Positioning for the Future of Ocular and Systemic Disease Care

4 months ago - By: RetinalGeniX Technologies, Inc.

RetinalGenix Technologies Contracts with LabCorp to Support DNA/GPS Platform for Advanced Genetic and Retinal Health Screening

4 months ago - By: RetinalGeniX Technologies, Inc.

RetinalGenix Technologies Contracts with LabCorp to Support DNA/GPS Platform for Advanced Genetic and Retinal Health Screening

5 months ago - By: RetinalGeniX Technologies, Inc.

RetinalGenix Technologies Welcomes Dr. Taimour Langaee as Advisor for DNA GPS Pharmacogenetics Initiatives

5 months ago - By: RetinalGeniX Technologies, Inc.

RetinalGenix Technologies Welcomes Dr. Taimour Langaee as Advisor for DNA GPS Pharmacogenetics Initiatives

6 months ago - By: RetinalGeniX Technologies, Inc.

RetinalGenix Technologies, Inc. Announces Laboratory Lease Agreement with Life Science Incubator MBC BioLabs

6 months ago - By: RetinalGeniX Technologies, Inc.

RetinalGenix Technologies, Inc. Announces Laboratory Lease Agreement with Life Science Incubator MBC BioLabs

8 months ago - By: RetinalGeniX Technologies, Inc.

RetinalGenix Technologies to Participate at the 37th Annual Roth Conference

8 months ago - By: RetinalGeniX Technologies, Inc.

RetinalGenix Technologies to Participate at the 37th Annual Roth Conference

8 months ago - By: RetinalGeniX Technologies, Inc.

RetinalGenix Technologies Breakthrough in Real-Time 24/7 Remote Ocular Monitoring

8 months ago - By: RetinalGeniX Technologies, Inc.

RetinalGenix Technologies Breakthrough in Real-Time 24/7 Remote Ocular Monitoring

2 years ago - By: RetinalGeniX Technologies, Inc.

RetinalGeniX™ Technologies Inc. Granted a Patent for System And Method For Visualization Of Ocular Anatomy

2 years ago - By: RetinalGeniX Technologies, Inc.

RetinalGeniX™ Technologies Inc. Granted a Patent for System And Method For Visualization Of Ocular Anatomy

2 years ago - By: RetinalGeniX Technologies, Inc.

RetinalGeniX™ Technologies Inc. Contracts With MEDsan, Inc. to Provide Diagnostic Testing Services for Its Institutional Review Board to Conduct a Study to Personalize Medical Evaluations for Patients Receiving Treatment for Wet Macular Degeneration

2 years ago - By: RetinalGeniX Technologies, Inc.

RetinalGeniX Technologies Inc. Appoints Anatoly Dritschilo, M.D. to the Company’s Medical Advisory Board

2 years ago - By: RetinalGeniX Technologies, Inc.

RetinalGeniX™ Technologies Inc. Contracts With MEDsan, Inc. to Provide Diagnostic Testing Services for Its Institutional Review Board to Conduct a Study to Personalize Medical Evaluations for Patients Receiving Treatment for Wet Macular Degeneration

2 years ago - By: RetinalGeniX Technologies, Inc.

RetinalGeniX Technologies Inc. Appoints Anatoly Dritschilo, M.D. to the Company’s Medical Advisory Board

2 years ago - By: RetinalGeniX Technologies, Inc.

RetinalGeniX Technologies Inc. Appoints Dessy Boneva, MD, FACS to the Board of Directors

2 years ago - By: RetinalGeniX Technologies, Inc.

RetinalGeniX Technologies Inc. Appoints Dessy Boneva, MD, FACS to the Board of Directors

2 years ago - By: RetinalGeniX Technologies, Inc.

RetinalGeniX Technologies Inc. Announces Hiring of Interim CFO

2 years ago - By: RetinalGeniX Technologies, Inc.

RetinalGeniX Technologies Inc. Announces Hiring of Interim CFO

2 years ago - By: RetinalGeniX Technologies, Inc.

RetinalGeniX Technologies Inc. Appoints Stephen Tannenbaum to the Company's Business Advisory Board

2 years ago - By: RetinalGeniX Technologies, Inc.

RetinalGeniX Technologies Inc. Appoints Stephen Tannenbaum to the Company's Business Advisory Board

2 years ago - By: RetinalGeniX Technologies, Inc.

RetinalGeniX™ Technologies Inc. Announces the Submission of Two Provisional Patent Applications For Investigational Therapeutic Drugs

2 years ago - By: RetinalGeniX Technologies, Inc.

RetinalGeniX™ Technologies Inc. Announces the Submission of Two Provisional Patent Applications For Investigational Therapeutic Drugs

2 years ago - By: RetinalGeniX Technologies, Inc.

RetinalGeniX Contracts With Avania CRO to Provide Guidance for Interactions With FDA on Development of Two Drug Therapies and the RetinalCam™ Image Visualization Device

2 years ago - By: RetinalGeniX Technologies, Inc.

RetinalGeniX Contracts With Avania CRO to Provide Guidance for Interactions With FDA on Development of Two Drug Therapies and the RetinalCam™ Image Visualization Device

2 years ago - By: RetinalGeniX Technologies, Inc.

RetinalGeniX IRB Approved to Conduct Study to Personalize Medical Evaluations for Patients Receiving Treatment for Wet Macular Degeneration

2 years ago - By: RetinalGeniX Technologies, Inc.

RetinalGeniX IRB Approved to Conduct Study to Personalize Medical Evaluations for Patients Receiving Treatment for Wet Macular Degeneration

2 years ago - By: RetinalGeniX Technologies, Inc.

RetinalGeniX Technologies Inc. Focuses on Prevention of Blindness and Early Detection of Multiple Systemic Diseases

2 years ago - By: RetinalGeniX Technologies, Inc.

RetinalGeniX Technologies Inc. Focuses on Prevention of Blindness and Early Detection of Multiple Systemic Diseases

2 years ago - By: RetinalGeniX Technologies, Inc.

RetinalGenix Technologies Inc. Announces the Addition of Fred Chasalow, Ph.D., to the Medical Advisory Board of DNA-GPS

2 years ago - By: RetinalGeniX Technologies, Inc.

RetinalGenix Technologies Inc. Announces the Addition of Fred Chasalow, Ph.D., to the Medical Advisory Board of DNA-GPS

2 years ago - By: RetinalGeniX Technologies, Inc.

RetinalGeniX Technologies Inc. Granted Patent for Patient Home Monitoring and Physician Alert System for Ocular Anatomy

2 years ago - By: RetinalGeniX Technologies, Inc.

RetinalGeniX Technologies Inc. Granted Patent for Patient Home Monitoring and Physician Alert System for Ocular Anatomy